FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

FDA Upping Drug Inspections in India: McMullen

FDA India director Sarah McMullen says the agency is working to increase drug inspections in India and station additional investigators there.

latest-news-card-1
Human Drugs

Viking Reports Favorable Trial, Data on Obesity Drug

Viking Therapeutics says its Phase 2 clinical trial of obesity drug VK2735, a dual agonist of glucagon-like peptide 1 and glucose-dependent insulinotr...

latest-news-card-1
Medical Devices

Alert Issued on Hologics BioZorb Markers

FDA issues a safety alert advising patients and healthcare providers about the potential risk of serious complications with Holigics BioZorb Marker an...

latest-news-card-1
Human Drugs

Wide Range of Rare Pediatric Treatments Developed

FDA researchers say a wide range of treatments for rare pediatric diseases have been developed in the 10 years since the pediatric disease priority re...

latest-news-card-1
Biologics

BeiGene BLA Filed for Gastric Cancer

FDA accepts for review a BeiGene BLA for Tevimbra (tislelizumab) for combination use with chemotherapy in treating locally advanced unresectable or me...

latest-news-card-1
Human Drugs

Complete Response Issued on Minerva Schizophrenia Drug

FDA sends Minerva Neurosciences a complete response letter on its NDA for roluperidone, indicated for treating negative symptoms in patients with schi...

latest-news-card-1
FDA General

Ex-FDA Lawyer Temkin Joins Paul Hastings

Former FDA associate chief counsel and CDER policy advisor Eva A. Temkin joins Paul Hastings as chair of the firms FDA practice.

latest-news-card-1
Medical Devices

Vyaire Recalls Airlife Resuscitator

Vyaire Medical recalls its AirLife Adult Manual Resuscitator and oxygen reservoir bag due to out-of-specification components used in manufacturing.

latest-news-card-1
Human Drugs

Milestone Pharma Refiling Etrpamil NDA

After receiving a 12/2023 FDA refuse-to-file letter, Milestone Pharmaceuticals now says it will resubmit the NDA in the second quarter for etripamil n...

latest-news-card-1
Federal Register

Animal Drug Regs Amended to Reflect Approvals

Federal Register notice: FDA amends its animal drug regulations to reflect application-related actions animal drug applications approved during the fo...